Roger Y Kim, MD MSCE

faculty photo
Assistant Professor of Medicine (Pulmonary, Allergy and Critical Care) at the Hospital of the University of Pennsylvania
Innovation Faculty Member, Penn Center for Cancer Care Innovation at the Abramson Cancer Center
Full Member, Abramson Cancer Center of the University of Pennsylvania
Senior Scholar, Center for Clinical Epidemiology and Biostatistics at the Perelman School of Medicine
Department: Medicine

Contact information
3400 Spruce Street
Philadelphia, PA 19104
BSc (Molecular, Cellular and Developmental Biology)
Yale University, 2010.
MD (Medicine)
Yale University, 2015.
MSCE (Clinical Epidemiology)
University of Pennsylvania, 2021.
Permanent link
> Perelman School of Medicine   > Faculty   > Details

Description of Clinical Expertise

Dr. Kim is an interventional pulmonologist at Penn Medicine. He has completed 8 years of post-graduate training and is triple-board certified in internal medicine, pulmonary disease, and interventional pulmonology. Dr. Kim has clinical expertise in pulmonology and medical critical care, and has received additional advanced training in interventional pulmonology and thoracic oncology. He specializes in treating patients with pulmonary nodules, abnormal chest CT scans, lung cancer, endobronchial disease, airway complications, pleural effusions, and chronic obstructive pulmonary disease, among other pulmonary conditions. Specifically, Dr. Kim has procedural expertise in diagnostic and therapeutic bronchoscopy, rigid bronchoscopy, robotic bronchoscopy, advanced navigational bronchoscopic techniques, endobronchial ultrasound-guided transbronchial needle aspiration and biopsy, balloon bronchoplasty, relief of airway stenosis, foreign body removal, endobronchial tumor debulking, airway stent placement, endoscopic airway electrosurgery, chest tube insertion, indwelling tunneled pleural catheter placement, and percutaneous tracheostomy, among other minimally invasive procedures.

Description of Research Expertise

Dr. Kim has received formal training in clinical epidemiology and biostatistics and has specific research expertise in clinical epidemiology, observational study design, clinical trial design, biostatistics, database management, data collection, statistical analysis, and scientific writing. His research aims to optimize the diagnostic process in thoracic oncology, with particular focuses on lung cancer screening and risk stratification of pulmonary nodules.

With the NCI-funded PROSPR-Lung Consortium, Dr. Kim has led multicenter studies evaluating disparities in lung cancer screening follow-up testing, which have identified opportunities to improve health equity in lung cancer screening care. Separately, he is invested in improving current pulmonary nodule risk stratification practices. Recent developments in technology have led to the development of a bevy of novel biomarkers designed to help clinicians risk stratify pulmonary nodules. His research seeks to determine the clinical utility and impact on medical decision-making of novel risk stratification biomarkers. He is the principal investigator for the NCI-funded (K08CA279881) ARCADES pragmatic randomized controlled trial to study the clinical effectiveness of an artificial intelligence radiomics-based biomarker (NCT05968898).

Selected Publications

Kim RY: Radiomics and Artificial Intelligence for Risk Stratification of Pulmonary Nodules: Ready for Primetime? Cancer Biomarkers February 2024 Notes: DOI: 10.3233/CBM-230360.

Rendle KA, Saia CA, Vachani A, Burnett-Hartman AN, Doria-Rose VP, Beucker S, Neslund-Dudas C, Oshiro C, Kim RY, Elston-Lafata J, Honda SA, Ritzwoller D, Wainwright JV, Mitra N, Greenlee RT: Rates of Downstream Procedures and Complications Associated with Lung Cancer Screening in Routine Clinical Practice: A Retrospective Cohort Study. Annals of Internal Medicine 177(1): 18-28, January 2024.

Ibrahim R, Sakr L, Kim RY, Benn BS, Low S: Social Vulnerability and Lung Malignancy Mortality. Journal of Cancer Policy 38:100453, December 2023.

DiBardino DM, Kim RY, Cao Y, Andronov M, Lanfranco AR, Haas AR, Vachani A, Ma KC, Hutchinson CT.: Diagnostic Yield of Cone-beam-Derived Augmented Fluoroscopy and Ultrathin Bronchoscopy Versus Conventional Navigational Bronchoscopy Techniques. J Bronchology Interv Pulmonol 30(4): 335-345, Oct 2023.

Burnett-Hartman AN, Carroll NM, Croswell JM, Greenlee RT, Honda SA, Neslund-Dudas CM, Kim RY, Rendle KA, Vachani A, Ritzwoller DP.: Percentage Up to Date With Chest Computed Tomography Among Those Eligible for Lung Cancer Screening. Am J Prev Med 65(1): 126-130, July 2023.

Kim RY, Oke JL, Dotson TL, Bellinger CR, Vachani A.: Effect of an Artificial Intelligence Tool on Management Decisions for Indeterminate Pulmonary Nodules. Respirology 28(6): 582-584, June 2023.

Zhang C, Kim RY, McGrath CM, Andronov M, Haas AR, Ma KC, Lanfranco AR, Hutchinson CT, Morrissette JJD, DiBardino DM.: The Performance of an Extended Next Generation Sequencing Panel Using Endobronchial Ultrasound-Guided Fine Needle Aspiration Samples in Non-Squamous Non-Small Cell Lung Cancer: A Pragmatic Study. Clin Lung Cancer 24(2): e105-e112, March 2023.

Kim RY, Rendle KA, Mitra N, Saia CA, Neslund-Dudas C, Greenlee RT, Burnett-Hartman AN, Honda SA, Simoff MJ, Schapira MM, Croswell JM, Meza R, Ritzwoller DP, Vachani A.: Socioeconomic Status as a Mediator of Racial Disparity in Annual Lung Cancer Screening Adherence. Am J Respir Crit Care Med 207(6): 777-780, March 2023.

Kim RY, Oke JL, Pickup LC, Munden RF, Dotson TL, Bellinger CR, Cohen A, Simoff MJ, Massion PP, Filippini C, Gleeson FV, Vachani A.: Artificial Intelligence Tool for Assessment of Indeterminate Pulmonary Nodules Detected with CT. Radiology 304(3): 683-691, September 2022.

Kim RY, Sterman DH, Haas AR.: Malignant Mesothelioma: Has Anything Changed? Semin Respir Crit Care Med 40(3): 347-360, June 2019.

Kim RY, Mitra N, Bagley SJ, Marmarelis ME, Haas AR, Rendle KA, Vachani A.: Immune Checkpoint Inhibitor Uptake in Real-World Patients With Malignant Pleural Mesothelioma. JTO Clin Res Rep 2(6): 100188, May 2021.

Parikh RB, Takvorian SU, Vader D, Paul Wileyto E, Clark AS, Lee DJ, Goyal G, Rocque GB, Dotan E, Geynisman DM, Phull P, Spiess PE, Kim RY, Davidoff AJ, Gross CP, Neparidze N, Miksad RA, Calip GS, Hearn CM, Ferrell W, Shulman LN, Mamtani R, Hubbard RA; PRACTICE Investigators.: Impact of the COVID-19 Pandemic on Treatment Patterns for Patients With Metastatic Solid Cancer in the United States. J Natl Cancer Inst 114(4): 571-578, Apr 2022.

Kim RY, Li Y, Marmarelis ME, Vachani A.: Comparative effectiveness of second-line immune checkpoint inhibitor therapy versus chemotherapy for malignant pleural mesothelioma. Lung Cancer 159: 107-110, September 2021.

Kim RY, Rendle KA, Mitra N, Saia CA, Neslund-Dudas C, Greenlee RT, Burnett-Hartman AN, Honda SA, Simoff MJ, Schapira MM, Croswell JM, Meza R, Ritzwoller DP, Vachani A.: Racial Disparities in Adherence to Annual Lung Cancer Screening and Recommended Follow-Up Care: A Multicenter Cohort Study. Ann Am Thorac Soc 19(9): 1561-1569, September 2022.

Kim RY, Haas AR.: Endobronchial Ultrasound. Diagnostic and Interventional Bronchoscopy in Children. Samuel Goldfarb, Joseph Piccione (eds.). Springer, 2020 Notes: ISBN: 978-3-030-54923-7.

back to top
Last updated: 05/13/2024
The Trustees of the University of Pennsylvania